SEC Form 4 · accession 0001209191-18-010105
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey M Leiden
Officer — CEO & President · Director
Period of report
Feb 12, 2018
Accepted (ET)
Feb 14, 2018 · 6:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Feb 12, 2018 | S | 6,100 | $149.22 | D | 208,463 | D | |
| Common StockF3,F4 | Feb 12, 2018 | S | 4,305 | $150.44 | D | 204,158 | D | |
| Common StockF3,F5 | Feb 12, 2018 | S | 10,100 | $151.23 | D | 194,058 | D | |
| Common StockF3,F6 | Feb 12, 2018 | S | 1,200 | $152.40 | D | 192,858 | D | |
| Common StockF3,F7 | Feb 12, 2018 | S | 2,000 | $153.29 | D | 190,858 | D | |
| Common StockF3,F8 | Feb 12, 2018 | S | 200 | $153.89 | D | 190,658 | D | |
| Common Stock | holding | — | — | — | 440 | I | 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1.
- F2Open market sales reported on this line occurred at a weighted average price of $149.22 (range $148.77 to $149.74).
- F3Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F4Open market sales reported on this line occurred at a weighted average price of $150.44 (range $149.79 to $150.76).
- F5Open market sales reported on this line occurred at a weighted average price of $151.23 (range $150.83 to $151.82).
- F6Open market sales reported on this line occurred at a weighted average price of $152.40 (range $151.85 to $152.81).
- F7Open market sales reported on this line occurred at a weighted average price of $153.29 (range $152.88 to $153.84).
- F8Open market sales reported on this line occurred at a weighted average price of $153.89 (range $153.88 to $153.89).